11-1956389-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_021134.4(MRPL23):c.431G>A(p.Arg144Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R144W) has been classified as Uncertain significance.
Frequency
Consequence
NM_021134.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MRPL23 | NM_021134.4 | c.431G>A | p.Arg144Gln | missense_variant | 5/5 | ENST00000397298.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MRPL23 | ENST00000397298.8 | c.431G>A | p.Arg144Gln | missense_variant | 5/5 | 1 | NM_021134.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000153 AC: 2AN: 131146Hom.: 0 Cov.: 17
GnomAD3 exomes AF: 0.000106 AC: 25AN: 236708Hom.: 0 AF XY: 0.0000773 AC XY: 10AN XY: 129370
GnomAD4 exome AF: 0.00000596 AC: 7AN: 1175278Hom.: 0 Cov.: 20 AF XY: 0.00000513 AC XY: 3AN XY: 584600
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000153 AC: 2AN: 131146Hom.: 0 Cov.: 17 AF XY: 0.0000319 AC XY: 2AN XY: 62712
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.431G>A (p.R144Q) alteration is located in exon 5 (coding exon 5) of the MRPL23 gene. This alteration results from a G to A substitution at nucleotide position 431, causing the arginine (R) at amino acid position 144 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at